Angiographically detected coronary aneurysms secondary to atherosclerosis are relatively uncommon findings 1 . Their natural history is not well defined. Potential complications are rupture, thrombosis, and embolism 2 . They are difficult to treat, and a therapeutic approach to treatment has rarely been described 3 . This is a case of an atherosclerotic coronary artery aneurysm obliterated by a covered stent only recently available on the market.
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Case Report
A 72-year-old woman with typical precordial pain of 2-hours duration was admitted to the emergency room. A physical examination showed she was anxious and in considerable distress. Cold perspiration and skin pallor were evident. Her heart rate was 55 beats/min, while her blood pressure was l00/60mmHg. Marked elevation of ST-segment existed in the inferior leads. The patient was treated immediately with an intravenous thrombolytic agent (streptokinase l,500,000 UI). Clinical and electrocardiographic findings indicated that the agent restored vessel patency. The patient had no complications until day 5 when she experienced precordial pain of short duration. Coronary arteriography revealed moderate hypokinesia in the posterior-basal wall of the left ventricle, left anterior descending and left circumflex coronary arteries without critical lesions and an aneurysm, measuring 6.7mm in diameter (measured by Automated Coronary Analysis software for the digital Philips, INTEGRIS H 5000), at the mid portion of the right coronary artery ( fig. 1-A) . Two tight stenoses were present at the distal and proximal parts of the aneurysm.
The decision to treat with angioplasty and stent implantation in the next few days was made. Administration of l00mg daily of aspirin was maintained, and 75mg daily of clopidogrel was started. Two days later, the patient underwent a percutaneous coronary intervention. The guiding catheter used was a JR4 8F (Cordis, Brite tip) placed through the right femoral artery. After administration of l0,000 IU of heparin, the lesions and the aneurysm were crossed with a 0.014-inch guidewire (standard). Plain balloon angioplasty of the distal lesion was performed with a 3.0x20-mm balloon at an inflation pressure of 8 atmospheres. Subsequently, the more proximal lesion was dilated with a 3.5x20-mm balloon at 10 atmospheres. Then a 2.5-5.0x26-mm covered stent (jostent graft, Jomed, Germany) was hand-crimped on a 3.0x30-mm low-compliance balloon and was deployed at an inflation pressure of l0 atmospheres. Excellent angiographic results were achieved after an additional dilation with a 3.5x20-mm balloon at an inflation pressure of l4 atmospheres ( fig. 2) . The patient experienced transient hypotension responsive to volume expansion. No distal embolization was observed.
The patient was discharged 2 days after stent implantation on l00mg of aspirin daily and 75mg of clopidogrel daily. Clopidogrel was administered for 2 months after the procedure. An exercise stress test performed 4 months after intervention was considered negative for myocardial ischemia. A follow-up coronary angiography performed 5 months after the implantation procedure showed sustained initial results ( fig. 3 ). One year after stenting, the patient remains well and has had no chest pain.
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Discussion
Atherosclerotic coronary artery aneurysm occurs infrequently and has no known appropriate therapy.
Conservative management has potential complications, such as rupture, tamponade, thrombosis with distal embolization, arterial occlusion, and sudden death 4, 5 . Surgery with ligation of the aneurysm and distal bypass is the alternative for high-risk patients 6 . Several reports of percutaneous occlusions of coronary aneurysms have been described recently 6 . Few cases of coronary artery aneurysm obliteration with PTFE-covered stents have been reported in the literature [7] [8] [9] . This is a case study of a patient presenting 
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with a coronary aneurysm and an acute myocardial infarction (AMI). Myocardial infarction and angina are common in patients with coronary ectasia, and the natural history is comparable to that in patients with advanced coronary obstructive disease 10 . The coronary aneurysm had a long neck and could not be obliterated by a noncovered stent in this patient. The novel device, consisting of 2 stents with a layer of expandable graft material resulted in complete exclusion of the aneurysm ( fig. 2) . In PTFE grafts, a delayed endothelization occurs because its principal mechanism is in-growth from the margins 11 . The clinical significance of atherosclerotic coronary artery aneurysms remains a controversial topic of discussion 12, 13 . In this patient, the indication for covering the aneurysm was the proximity of 2 tight coronary stenoses. Sustained angiographic results existed 5 months after intervention. It seems that covered stents offer a viable solution for aneurysm obliteration. Their disadvantages are larger profiles and less flexibility compared with ordinary stents. A B
